Collagenous Gastritis in Children: Incidence, Disease Course, and Associations With Autoimmunity and Inflammatory

Timo Käppi1,2, Alkwin Wanders3,4, Mats Wolving5

  • 1Department of Pediatric Gastroenterology, Hepatology and Nutrition, Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Göteborg, Sweden.

Insights

Childhood collagenous gastritis (CG) is rare and chronic. While autoimmune predisposition is common, autoimmune diseases are infrequent, with serum calprotectin and amyloid A as potential inflammatory biomarkers.

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Rare Diseases

Background:

  • Collagenous gastritis (CG) is a rare disorder with an unknown cause, potentially involving immune mechanisms.
  • Understanding the characteristics and autoimmune associations of childhood-onset CG is crucial for diagnosis and management.

Purpose of the Study:

  • To determine the incidence and prevalence of childhood-onset CG.
  • To describe the clinical, endoscopic, and histologic features of pediatric CG.
  • To investigate evidence of autoimmunity and inflammatory activity in children with CG.

Main Methods:

  • A longitudinal review of 15 pediatric CG patients in Sweden (2008-2019).
  • Analysis of autoantibodies, inflammatory biomarkers (calprotectin, amyloid A, C-reactive protein), and HLA-DQ2/DQ8 genotype.
  • Cross-sectional analysis of autoimmune markers and disease course during follow-up.

Main Results:

  • Childhood CG incidence was 0.25/100,000 person-years; prevalence was 2.1/100,000. Girls were more affected (4.2:1 ratio).
  • Disease remained active throughout a median 4.4-year follow-up. Autoimmune predisposition was common (47% heredity, 40% autoantibodies, 53% HLA-DQ2/DQ8).
  • Elevated serum calprotectin (67%) and amyloid A (33%) were observed; C-reactive protein was mostly normal. No autoimmune comorbidities were noted.

Conclusions:

  • Childhood-onset CG is a rare condition with a chronic course.
  • Autoimmune predisposition is frequent, but overt autoimmune diseases are uncommon in early childhood.
  • Serum calprotectin and amyloid A may serve as novel biomarkers for inflammatory activity in CG.
Abstract

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
967
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
1.8K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
732
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
928
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
532
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
664